Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study

QR Code

Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study

Aim. To study the effects of taurine therapy on the occurrence of cardiac arrhythmias and QT interval dispersion (dQT) among patients with postinfarction cardiosclerosis (PICS) and subsequent chronic heart failure (CHF). Material and methods. The study included 40 patients with previous myocardial i...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. G. Gordeev, E. M. Pokrovskaya, E. E. Luchinkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	chronic heart failure taurine dqt cardiac arrhythmias
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1701
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TAURIN INFLUENCE ON CLINICAL COURSE OF STAbLE ANGINA IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: I. S. Vasilieva, et al.
Published: (2018-05-01)

TAURINE IN INTERNAL MEDICINE
by: E. M. Pokrovskaya, et al.
Published: (2011-02-01)

QT and QTa interval duration and dispersion during stress test in coronary heart disease and ventricular arrhythmia patients
by: N. V. Furman, et al.
Published: (1970-01-01)

Sinus arrhythmia effects on QT dispersion parameters in healthy individuals and coronary heart disease patients
by: P. Ya. Dovgalevsky, et al.
Published: (1970-01-01)

Effect of methionine replacement with taurine on the performance and antioxidative capacity of broiler
by: Elham Ghashghaei, et al.
Published: (2025-09-01)

Industrial synthesis of 2-aminoethanesulfonic acid (taurine): problems and perspectives
by: N. Yu. Rubanyak, et al.
Published: (2010-06-01)

Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations
by: Saltanat Nakypova, et al.
Published: (2025-07-01)

Taurine Alleviates Pancreatic β‐Cell Senescence by Inhibition of p53 Pathway
by: Baomin Wang, et al.
Published: (2025-06-01)

Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions
by: G. N. Mozhokina, et al.
Published: (2020-05-01)

Effects of amino acids methionine, lysine, and taurine on feed intake and mRNA expression of appetite-related neuropeptides in layer-type chicks
by: Elham Ghashghaei, et al.
Published: (2025-10-01)

Energy Drinks - the potential risk to the cardiovascular system. A Review
by: Michalina Piwowar, et al.
Published: (2025-06-01)

A Novel Mesoporous Taurine-Doped Polyaniline/PVA Electrospun Composite Nanofiber: Comprehensive Study
by: M.S. Archana, et al.
Published: (2025-08-01)

PROSPECTS DOMESTIC DRUGS DIBIKOR (TAURINE) IN PATIENTS WITH MYOCARDIAL INFARCTION, AND STABLE ANGINA
by: V. V. Rezvan, et al.
Published: (2016-06-01)

Theranostic Applications of Taurine-Derived Carbon Dots in Colorectal Cancer: Ferroptosis Induction and Multifaceted Antitumor Mechanisms
by: Zhang R, et al.
Published: (2025-06-01)

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION
by: N. V. Furman, et al.
Published: (2015-09-01)

Peranan Taurin pada Pertumbuhan dan Kelangsungan Hidup Larva Ikan Kerapu Bebek Cromileptes altivelis (Valenciennes, 1828)
by: Regina Melianawati, et al.
Published: (2023-03-01)

Effects of Paranosema locustae (Microsporidia) on the development and morphological phase transformation of Locusta migratoria (Orthoptera: Acrididae) through modulation of the neurotransmitter taurine
by: Ao-mei LI, et al.
Published: (2020-01-01)

Taurine supplementation decreases fat accumulation by suppressing FAS and enhancing ATGL through the ATGL pathway
by: Xueying Geng, et al.
Published: (2024-12-01)

ASSOCIATION BETWEEN CARDIAC ARRHYTHMIAS, INTRACARDIAC AND CENTRAL HEMODYNAMICS IN PATIENTS WITH POST-INFARCTION CARDIOSCLEROSIS AND MITRAL REGURGITATION
by: N. A. Volov, et al.
Published: (2010-04-01)

MORPHOFUNCTIONAL FEATURES OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND ARTERIAL HYPERTENSION, DEPENDING ON THE AFFECTED CORONARY REGION
by: A. M. Valeeva, et al.
Published: (2019-09-01)

Effect of benzoyl taurine dipotassium salt on coagulation, hemostasis and vascular activity in the microvasculature of the brain in violation of cerebral circulation
by: V. E. Pustynnikov, et al.
Published: (2022-10-01)

Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01)

Development, Validation and Approbation Analytical Method for the Quantitative Determination of Taurine by HPLC-UV Method in the Test of Comparative Dissolution Kinetics
by: A. M. Poluyanov, et al.
Published: (2023-05-01)

Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome
by: I. V. Kryuchkova, et al.
Published: (1970-01-01)

Clinical-pharmacological aspects of the safe use of medicines, causing prolongation of QT interval
by: O. A. Demidova, et al.
Published: (2018-02-01)

Neuromodulation of the Cardiac Autonomic Nervous System for Arrhythmia Treatment
by: Benjamin Wong, et al.
Published: (2025-07-01)

HEART RATE AND QT VARIABILITY IN PATIENTS WITH METABOLIC SYNDROME COMPLICATED BY CARDIAC ARRHYTHMIA
by: E. D. Dzhishambaev, et al.
Published: (2012-06-01)

Effects of Rumen-Protected Taurine Supplementation on Ruminal Fermentation, Hematological Profiles, Liver Function, and Immune Responses in Yaks
by: Shoupei Zhao, et al.
Published: (2025-06-01)

Assessment of the feed additive consisting of taurine (3a370) for Canidae, Felidae, Mustelidae and carnivorous fish for the renewal of its authorisation and the request for a new use in all poultry and all porcine species (Regal B. V.)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-07-01)

THE MORPHOLOGY OF ELECTROPHYSIOLOGICAL DISORDERS OF MYOCARDIUM IN POSTINFARCTION ANEURYSM AND VENTRICULAR TACHICARDIA
by: V. E. Babokin, et al.
Published: (2015-11-01)

QT Interval and QT Variability
by: Vrtovec, Bojan, et al.
Published: (2012)

Investigation on the action mechanisms of taurine on rumen microbial crude protein synthesis and nitrogen metabolism in beef steers using sodium sulfate as a contrast
by: Manman Fan, et al.
Published: (2025-09-01)

DEVELOPMENT AND STUDY OF THE CHARACTERISTICS OF OPHTHALMIC GELS BASED ON CARBOMER ACRYPOL 974P AND CADPOL 980
by: Y. M. Domnina, et al.
Published: (2019-01-01)

Attenuating effect of taurine on oxidative damage and Nrf2/HO-1 pathway induced by cadmium in testicular cells of embryonic chickens
by: LIU Mengqi, et al.
Published: (2018-09-01)

Electrical alternans of the Q-T interval and fatal arrhythmias caused by neonatal cardiac tumor: a case report
by: Ge Wang, et al.
Published: (2025-07-01)

Right ventricular visualization at SPECT perfusion imaging before and after revascularization in patients with postinfarction cardiosclerosis
by: E. N. Ostroumov, et al.
Published: (2023-06-01)

Duration and dispersion of QT interval in patients with liver cirrhosis: diagnostic and prognostic value
by: V. V. Genkel, et al.
Published: (2025-02-01)

Cardiac arrhythmia prevalence in postmenopausal women
by: N. V. Izmozherova, et al.
Published: (2011-06-01)

Influence of L-carnitine on reactive oxygen species production by blood phagocytes in postinfarction cardiosclerosis patients
by: E. I. Astashkin, et al.
Published: (2016-10-01)

Relationship between cardiac arrhythmias and anticancer therapy
by: V. I. Potievskaya, et al.
Published: (2020-11-01)